Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/197180
Title: Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients
Author: Sans de San Nicolàs, Lídia
Figueras Nart, Ignasi
García-Jiménez, Irene
Bonfill Ortí, Montserrat
Guilabert, Antonio
Curto Barredo, Laia
Bertolín Colilla, Marta
Ferran, Marta
Serra Baldrich, Esther
Pujol, Ramon M.
Santamaria Babí, Luis F.
Keywords: Dermatitis atòpica
Al·lèrgens
Citocines
Cèl·lules T
Atopic dermatitis
Allergens
Cytokines
T cells
Issue Date: 13-Mar-2023
Publisher: Frontiers Media SA
Abstract: Background:The role of allergen sensitization in IL-31 production by T cells and specifically in the clinical context of atopic dermatitis (AD) has not been characterized. MethodsThe response to house dust mite (HDM) in purified memory T cells cocultured with epidermal cells from AD patients (n=58) and control subjects (n=11) was evaluated. AD-associated cytokines from culture supernatants, plasma proteins and mRNA expression from cutaneous lesions were assessed and related with the clinical features of the patients. ResultsHDM-induced IL-31 production by memory T cells defined two subsets of AD patients according to the presence or absence of IL-31 response. Patients in the IL-31 producing group showed a more inflammatory profile, and increased HDM-specific (sp) and total IgE levels compared to the IL-31 non-producing group. A correlation between IL-31 production and patient's pruritus intensity, plasma CCL27 and periostin was detected. When the same patients were analyzed based on sp IgE and total IgE levels, an increased IL-31 in vitro response, as well as type 2 markers in plasma and cutaneous lesions, was found in patients with sp IgE levels > 100 kUA/L and total IgE levels > 1000 kU/L. The IL-31 response by memory T cells was restricted to the cutaneous lymphocyte-associated antigen (CLA)(+) T-cell subset. ConclusionIgE sensitization to HDM allows stratifying IL-31 production by memory T cells in AD patients and relating it to particular clinical phenotypes of the disease.
Note: Reproducció del document publicat a: https://doi.org/10.3389/fimmu.2023.1124018
It is part of: Frontiers in Immunology, 2023, vol. 14, num. 1124018
URI: https://hdl.handle.net/2445/197180
Related resource: https://doi.org/10.3389/fimmu.2023.1124018
ISSN: 1664-3224
Appears in Collections:Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
fimmu-14-1124018.pdf2.92 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons